Technical Analysis for ARPO - Aerpio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.65 -1.52% -0.01
ARPO closed down 1.52 percent on Wednesday, August 21, 2019, on 2.22 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical ARPO trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup -1.52%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.52%
NR7 Range Contraction -1.52%
NR7-2 Range Contraction -1.52%
Wide Bands Range Expansion -1.52%

Older signals for ARPO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company is headquartered in Cincinnati, Ohio. Aerpio Pharmaceuticals, Inc. operates independently of Akebia Therapeutics, Inc. as of December 22, 2011.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Monoclonal Antibodies Inflammatory Bowel Disease Diabetic Retinopathy Treatment Of Inflammatory Bowel Disease Hypoxia Inducible Factors Retinopathy
Is ARPO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.25
52 Week Low 0.61
Average Volume 88,364
200-Day Moving Average 1.7127
50-Day Moving Average 0.8117
20-Day Moving Average 0.7069
10-Day Moving Average 0.6586
Average True Range 0.0531
ADX 51.91
+DI 8.1539
-DI 17.4381
Chandelier Exit (Long, 3 ATRs ) 0.6807
Chandelier Exit (Short, 3 ATRs ) 0.7693
Upper Bollinger Band 0.8227
Lower Bollinger Band 0.5911
Percent B (%b) 0.25
BandWidth 32.762767
MACD Line -0.0518
MACD Signal Line -0.0525
MACD Histogram 0.0007
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.74
Resistance 3 (R3) 0.74 0.72 0.73
Resistance 2 (R2) 0.72 0.69 0.72 0.72
Resistance 1 (R1) 0.68 0.68 0.67 0.68 0.71
Pivot Point 0.66 0.66 0.65 0.66 0.66
Support 1 (S1) 0.62 0.63 0.61 0.62 0.59
Support 2 (S2) 0.60 0.62 0.60 0.58
Support 3 (S3) 0.56 0.60 0.58
Support 4 (S4) 0.56